BLUE : Insider Transactions for Bluebird Bio, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bluebird Bio, Inc. (BLUE)

$0.97 0.00 (-0.29%) as of 4:30 Fri 5/24

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

139,126,000

Market Cap:

134.45(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.8871 - $4.83

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	17,438	35,533	57,514	116,582
Total Sell Value	$26,639	$61,294	$139,194	$443,003
Total People Sold	3	5	5	9
Total Sell Transactions	3	9	12	23
End Date	2024-02-25	2023-11-24	2023-05-26	2022-05-26

Adjust Filter Settings

Records found: 939

Page 22 of 38

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2017-06-06

4

AS

$100.14

$226,622

D/D

(2,263)

1,400

-

Director

– • –

2017-06-06

4

OE

$2.09

$4,722

D/D

2,263

3,663

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-06-06

4

AS

$100.05

$250,135

D/D

(2,500)

27,305

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-06-06

4

OE

$2.09

$5,216

D/D

2,500

29,805

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-06-06

4

AS

$99.04

$148,560

D/D

(1,500)

35,779

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-06-06

4

OE

$50.51

$50,510

D/D

1,000

37,279

-

Chief Legal Officer

• – –

2017-06-06

4

AS

$100.22

$1,684,705

D/D

(16,810)

15,801

-

Chief Legal Officer

• – –

2017-06-06

4

OE

$22.53

$427,415

D/D

16,810

32,611

-

Chief Medical Officer

• – –

2017-06-05

4

AS

$90.00

$90,002

D/D

(1,000)

17,177

-

Chief Medical Officer

• – –

2017-06-05

4

OE

$2.09

$2,090

D/D

1,000

18,177

-

Director

– • –

2017-06-05

4

AS

$90.00

$90,002

D/D

(1,000)

1,400

-

Director

– • –

2017-06-05

4

OE

$2.09

$2,086

D/D

1,000

2,400

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-06-01

4

AS

$75.48

$113,430

D/D

(1,500)

36,279

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-06-01

4

OE

$50.51

$37,883

D/D

750

37,779

-

Chief Medical Officer

• – –

2017-06-01

4

AS

$75.42

$150,849

D/D

(2,000)

17,177

-

Chief Medical Officer

• – –

2017-06-01

4

OE

$2.09

$4,180

D/D

2,000

19,177

-

Director

– • –

2017-05-25

4

AS

$80.00

$160,001

D/D

(2,000)

1,400

-

Director

– • –

2017-05-25

4

OE

$2.09

$4,173

D/D

2,000

3,400

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-05-10

4

AS

$88.77

$110,966

D/D

(1,250)

27,305

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2017-05-10

4

OE

$5.50

$6,876

D/D

1,250

28,555

-

Chief Medical Officer

• – –

2017-05-01

4

AS

$87.58

$266,208

D/D

(3,000)

17,177

-

Chief Medical Officer

• – –

2017-05-01

4

OE

$2.09

$6,270

D/D

3,000

20,177

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-05-01

4

AS

$87.73

$132,109

D/D

(1,500)

37,029

-

Gregory Philip D

Chief Scientific Officer

• – –

2017-05-01

4

OE

$50.51

$37,883

D/D

750

38,529

-

Director

– • –

2017-04-27

4

AS

$90.01

$90,010

D/D

(1,000)

1,400

-

939 Records found	Previous 20 21 22 23 24 25 26 27 28 29 Next	Page 22 of 38

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.